DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1BELRAPZO
02 1CYCLOPHOSPHAMIDE
03 1TEMSIROLIMUS
04 1TORSEMIDE
01 190656
02 1203153
03 1205580
04 1212501
01 2No
02 2Yes
Drug : CYCLOPHOSPHAMIDE
Dosage Form : SOLUTION; INTRAVENOUS
Application Number : 212501
Country : US
Patented : Yes
Drug : TEMSIROLIMUS
Dosage Form : SOLUTION; INTRAVENOUS
Application Number : 203153
Country : US
Patented : No
Drug : TORSEMIDE
Dosage Form : SOLUTION; INTRAVENOUS
Application Number : 90656
Country : US
Patented : No
Drug : BELRAPZO
Dosage Form : SOLUTION; INTRAVENOUS
Application Number : 205580
Country : US
Patented : Yes
LOOKING FOR A SUPPLIER?